Merck (MRK) Current Assets (2009 - 2026)

Merck has disclosed Current Assets across 18 years of filings, most recently posting $35.0 billion for Q1 2026.

• In Q1 2026, Current Assets fell 1.37% year-over-year to $35.0 billion; the TTM figure through Mar 2026 stood at $35.0 billion (down 1.37% YoY), while the FY2025 annual figure was $43.5 billion, up 12.21% from the prior year.
• Current Assets slipped to $35.0 billion in Q1 2026, from $43.5 billion in the prior quarter.
• Over the last five years, Current Assets for MRK reached as high as $47.6 billion in Q3 2025 and fell as low as $30.0 billion in Q2 2023.
• The 5-year median for Current Assets is $35.0 billion (2026), against an average of $35.7 billion.
• Annual changes were most pronounced in 2023 — Current Assets slipped 9.95% — and 2024, when it grew 27.45%.
• A 5-year view of Current Assets shows it stood at $35.7 billion in 2022, then slipped by 9.95% to $32.2 billion in 2023, then increased by 20.56% to $38.8 billion in 2024, then climbed by 12.21% to $43.5 billion in 2025, then retreated by 19.54% to $35.0 billion in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $35.0 billion, $43.5 billion, and $47.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.